Robert Mallon
- Organic Chemistry top 5%
- Quinazolinone synthesis and applications 7
- Synthesis and biological activity 6
- Biotechnology top 5%
- Marine Sponges and Natural Products 5
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 13
- Melanoma and MAPK Pathways 12
- Protein Kinase Regulation and GTPase Signaling 11
- Toxicology top 5%
- Pharmacology top 5%
-
- Chronic Lymphocytic Leukemia Research 5
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Larry FeldbergIrwin HollanderAranapakam M. VenkatesanChristoph M. DehnhardtSemiramis Ayral‐KaloustianJudy LucasZecheng ChenDonald Wojciechowicz
- Journals
- Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (5 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Robert Mallon
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Organic Chemistry 615
- Biotechnology 145
- Molecular Biology 790
- Toxicology 38
- Pharmacology 175
Countries citing papers authored by Robert Mallon
This map shows the geographic impact of Robert Mallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mallon more than expected).
Fields of papers citing papers by Robert Mallon
This network shows the impact of papers produced by Robert Mallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mallon. The network helps show where Robert Mallon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Mallon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 145 | |
| 2 | 2011 | 30 | |
| 3 | 2010 | 52 | |
| 4 | 2010 | 18 | |
| 5 | 2010 | 26 | |
| 6 | 2010 | 59 | |
| 7 | 2010 | 21 | |
| 8 | 2009 | 32 | |
| 9 | 2009 | 23 | |
| 10 | 2009 | 16 | |
| 11 | 2008 | 16 | |
| 12 | Liphagal, a new meroterpenoid from the Caribbean sponge Aka coralliphaga that shows potent and selective inhibition of P13 kinase alpha. | 2006 | 0 |
| 13 | 2003 | 25 | |
| 14 | 2003 | 7 | |
| 15 | 2001 | 24 | |
| 16 | 2001 | 23 | |
| 17 | 2000 | 29 | |
| 18 | 1999 | 7 | |
| 19 | 1991 | 14 | |
| 20 | 1991 | 4 |
About Robert Mallon
Robert Mallon is a scholar working on Organic Chemistry, Biotechnology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (13 papers), Melanoma and MAPK Pathways (12 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Quinazolinone synthesis and applications (7 papers), Synthesis and biological activity (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Marine Sponges and Natural Products (5 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Organic Chemistry (615 citations), Biotechnology (145 citations), Molecular Biology (790 citations), Toxicology (38 citations) and Pharmacology (175 citations). Robert Mallon has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Larry Feldberg, Irwin Hollander, Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Semiramis Ayral‐Kaloustian, Judy Lucas, Zecheng Chen, Donald Wojciechowicz, Efren Delos Santos and Osvaldo dos Santos. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Clinical Cancer Research and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.